PatrickSEllsworthMD

PubMed

• 1 citations
  Targeting the von Willebrand Factor-ADAMTS-13 axis in sickle cell disease.
  Patrick Ellsworth, Erica M Sparkenbaugh> ;Journal of Thrombosis and Haemostasis. 2023 Jan 1
• 11 citations
  Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates?
  Patrick Ellsworth, Alice Ma> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
• 5 citations
  Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia A.
  Sheh-Li Chen, Patrick Ellsworth, Raj S. Kasthuri, Stephan Moll, Alice D. Ma, Nigel S. Key> ;Haemophilia. 2021 May 29
• 1 citations
  Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark.
  Patrick Ellsworth, Jane A Little> ;The Lancet. Haematology. 2021 May 1
• 3 citations
  A comprehensive epidemiological review of spinal astrocytomas in the United States.
  Jaes Jones, Patrick Ellsworth, Ghaith Habboub, Gino Cioffi, Nirav Patil, Quinn T. Ostrom, Carol Kruchko, Jill S. Barnholtz-Sloan, Varun R. Kshettry, Pablo F. Recinos> ;Journal of Neurosurgery. Spine. 2021 Feb 1
• Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy
  Patrick Ellsworth, Sheh-Li Chen, Nigel S. Key, Yasmina L. Abajas, Alice Ma> ;Haemophilia. 2021 Jan 1
• 15 citations
  Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.
  Patrick Ellsworth, Sheh-Li Chen, Raj S. Kasthuri, Nigel S. Key, Micah J. Mooberry, Alice D. Ma> ;Blood Advances. 2020 Dec 22
• 5 citations
  High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease.
  Erica M. Sparkenbaugh, Malgorzata Kasztan, Michael W. Henderson, Patrick Ellsworth, Parker Ross Davis, Kathryn Wilson, Brandi Reeves, Nigel S. Key, Sidney Strickland, ...> ;Journal of Thrombosis and Haemostasis. 2020 Jun 23
• 48 citations
  Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.
  Denis F. Noubouossie, Michael W. Henderson, Micah J. Mooberry, Anton Ilich, Patrick Ellsworth, Mark Piegore, Sarah Skinner, Rafal Pawlinski, Ian J. Welsby, Thomas Renn...> ;Blood. 2020 Mar 5
• 10 citations
  Pregnancy in sickle cell trait: what we do and don't know.
  Samuel Wilson, Patrick Ellsworth, Nigel S. Key> ;British Journal of Haematology. 2020 Feb 17
• 17 citations
  Development and application of global assays of hyper- and hypofibrinolysis.
  Anton Ilich, Denis F. Noubouossie, Michael W. Henderson, Patrick Ellsworth, Kathleen F. Betbadal, Elena Campello, Shannon L. Meeks, Amy L. Dunn, Myung S. Park, Rafal P...> ;Research and Practice in Thrombosis and Haemostasis. 2020 Jan 1
• 39 citations
  Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
  Camille Faes, Anton Ilich, Amandine Sotiaux, Erica M. Sparkenbaugh, Michael W. Henderson, Laura J. Buczek, Joan D. Beckman, Patrick Ellsworth, Denis F. Noubouossie, La...> ;Blood. 2019 Jun 6
• 38 citations
  Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract
  Brian Becknell, John David Spencer, Ashley R. Carpenter, Xi Chen, Aspinder Singh, Suzanne Ploeger, Jennifer Kline, Patrick Ellsworth, Birong Li, Ehrhardt Proksch, Andr...> ;Plos One. 2013 Oct 21
• Join now to see all

Lectures

• Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018